Isolated prenatal foramen ovale closure or restriction presenting after birth: a distinct, under-recognized clinical condition
Abstract
Background: The foramen ovale (FO) plays a central role in fetal circulation. Prenatal FO closure or restriction is well-characterized in fetuses and in neonates with congenital heart defects, but is rarely described as an isolated finding after birth. This study aimed to characterize the clinical presentation, echocardiographic features, management, and outcomes of neonates with isolated prenatal FO closure or restriction.
Methods: We retrospectively analyzed 10 consecutive neonates admitted to our tertiary neonatal intensive care unit between September 2018 and August 2025 with FO closure or restriction diagnosed after birth.
Results: The median gestational age was 39 + 1 weeks (range 36 + 4-41 + 1), and the median birth weight was 3,345 g (range 2,600-4,000 g). All the neonates presented within 9 h after birth, nine of them with central or differential cyanosis, seven with associated respiratory distress, and one with apnea. Echocardiography uniformly revealed persistent pulmonary hypertension of the newborn (PPHN) and significantly impaired left ventricular (LV) function with preserved right ventricular (RV) contractility. The interatrial septum was closed in six neonates and was restrictive in four. A prostaglandin infusion was administered to nine neonates. All the patients received inotropic support and pulmonary arterial hypertension (PAH) therapy. In survivors, normalization of LV function occurred in 1-4 days, followed by transition to a predominant left-to-right…
Read the paper
Related studies
- 2024 update in heart failure
- Vascular involvement in idiopathic pulmonary fibrosis
- A novel technique- subendometrial autologous platelet rich plasma injection in patients with unresponsive thin endometrium undergoing frozen-thawed embryo transfer: a prospective cohort study
- Does metformin prolong pregnancy in preterm pre-eclampsia? A study protocol for a South African, hospital-based double-blind, randomised, placebo-controlled trial
- Combined Pulmonary Fibrosis and Emphysema (CPFE): A "New" Smoking-Related Interstitial Lung Disease (ILD)
- Impact of an acute 1-month cannabidiol treatment on pain and inflammation after a long bone fracture: a triple-blind randomised, placebo-controlled, clinical trial protocol
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.